These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9665467)

  • 1. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.
    Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN
    Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
    Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
    Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts.
    Mannon RB; Doyle C; Griffiths R; Bustos M; Platt JL; Coffman TM
    Transplantation; 2000 May; 69(10):2137-43. PubMed ID: 10852613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
    Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
    Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations.
    Russell PS; Chase CM; Winn HJ; Colvin RB
    Am J Pathol; 1994 Feb; 144(2):260-74. PubMed ID: 7906094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-specific MHC class II gene expression in response to allogeneic stimulus in heterotopic murine cardiac allografts.
    Xu R; Burdick JF; Scott A; Beschorner WE; Adler W; Kittur DS
    Immunology; 1992 Feb; 75(2):361-5. PubMed ID: 1551698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.
    Shimizu K; Libby P; Rocha VZ; Folco EJ; Shubiki R; Grabie N; Jang S; Lichtman AH; Shimizu A; Hogg N; Simon DI; Mitchell RN; Croce K
    Circulation; 2011 Dec; 124(25):2920-32. PubMed ID: 22144572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients.
    Han WR; Murray-Segal LJ; Mottram PL
    Transpl Immunol; 1999 Mar; 7(1):37-44. PubMed ID: 10375076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging the rejecting heart. In vivo detection of major histocompatibility complex class II antigen induction.
    Isobe M; Narula J; Southern JF; Strauss HW; Khaw BA; Haber E
    Circulation; 1992 Feb; 85(2):738-46. PubMed ID: 1735166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas.
    Kelly KE; Hertz MI; Mueller DL
    Transplantation; 1998 Sep; 66(6):764-71. PubMed ID: 9771840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
    Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
    Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PECAM-1 in acute rejection of fully major histocompatibility complex class II-mismatched cardiac allografts in mice.
    Schramm R; Menger MD; Schmits R; Harder Y; Kirsch S; Meier C; Schäfers HJ
    Transplantation; 2007 Aug; 84(4):555-8. PubMed ID: 17713444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.